Neuro-ophthalmology
The clinical research activity is centered on acute anterior ischemic optic neuropathy, with attention to visual outcomes in the setting of Giant Cell Arteritis and Horton’s disease.
- Optic nerve ischemia
- Visual impairment
- Ischemic optic neuropathy
Interest in this area reflects a focus on conditions affecting the optic nerve and acute loss of vision.
Inflammatory vasculitis
The sponsor is involved in research on giant cell arteritis, with emphasis on its ocular complications and the inflammatory mechanisms linked to vascular injury.
- Giant cell arteritis
- Systemic vasculitis
- Arteritic ocular disease
This area connects vascular inflammation with sight-threatening ischemic events.
Immunomodulatory therapy
Research activity includes the use of tocilizumab alongside corticosteroid treatment for inflammatory eye disease associated with vasculitis.
- Interleukin-6 inhibition
- Biologic therapy
- Steroid-based treatment
The therapeutic interest lies in controlling immune-mediated vascular inflammation to support ocular recovery.
Acute vision-threatening disease
The trial portfolio addresses urgent ophthalmic conditions requiring close clinical management, particularly disorders with rapid onset and high risk of permanent visual loss.
- Ocular ischemia
- Acute visual loss
- Eye disease in vasculitis
Research in this domain is directed toward preserving visual function in inflammatory ischemic syndromes.
